1cтудентка 6-го курса Цырук Е. В.,
1cтудентка 6-го курса Поволоцкая Е. Ю.,
1доцент, к. мед. н. Макиенко Н. В.,
2Кротенко А. В.

1Украина, Харьков, Национальный университет имени В. Н. Каразина,
медицинский факультет, кафедра внутренней медицины
2Украина, Харьков, Клиническая больница на железнодорожном транспорте
Филиал №1 «Центр охорони здоров’я» Публичного акционерного общества «Українська залізниця»



In real clinical practice we often can meet patients with pathology of different systems. The number of multimorbidity states among of middle aged patients have a substantial increase. That is why we have new diagnostical and treatment tasks. Unsolved medicine combination problems, polypharmacy in category of the middle aged patients by the example of the clinical case
are discussed in the article.

Keywords: multimorbidity, polypharmacy, endocrinology, cardiovascular and rheumatology diseases.


1. Bayliss E. A., Steiner J. F., Fernald D. H. et al. Descriptions of barriers to self-care by
persons with comorbid chronic diseases. // Ann Fam Med. — 2003. — Vol. 1(1). — Р. 15-21.
2. Ferrer A., Formiga F., Sanz H. et al. Multimorbidity as specific disease combinations, an
important predictor factor for mortality in octogenarians: the Octabaix study. // Clin Interv Aging. — 2017. — №12. — Р. 223-231.
3. Hughes L. D., McMurdo M. E., Guthrie B. Guidelines for people not for diseases: the
challenges of applying UK clinical guidelines to people with multimorbidity. // Age Ageing. — 2013. — Vol. 42(1). — Р. 62-69.
4. Коломоєць М. Ю., Ващеняк О. О. Коморбідність і поліморбідність у терапевтичній
практиці. // Укр. мед. часопис. – 2012. – № 5 (91). – С. 134-143.
5. Lottmann K., Chen X., Schädlich P. K. Association between gout and all-cause as well as
cardiovascular mortality: a systematic review. // Curr. Rheumatol. Rep. — 2012. — Vol. 14(2). — P. 195–203.
6. Marengoni A., Angleman S., Fratiglioni L. Prevalence of disability according to
multimorbidity and disease clustering: a population based study. // Journal of Comorbidity. — 2011. — Vol. 1(1). — P. 11-18.
7. Khanna D., Fitzgerald J. D., Khanna P. P. et al. 2012 American College of Rheumatology
Guidelines for Management of Gout. Part 1: Systematic Nonpharmacologic and Pharmacologic
Therapeutic Approaches to Hyperuricemia. // Arthritis Care & Research. — 2012. — Vol. 10. — P.1431–1446.
8. Molokhia M., Majeed A. Current and future perspectives on the management of
polypharmacy. // BMC Fam Pract. — 2017. — Vol. 18(1). — Р.70.
9. Zhang M., Holman C. D., Price S. D. et al. Comorbidity and repeat admission to hospital
for adverse drug reactions in older adults: retrospective cohort study. // BMJ. — 2009. — Vol. 7. — P. 338.
10. Kongkaew C., Noyce P. R., Ashcroft D. M. Hospital admissions associated with adverse
drug reactions: a systematic review of prospective observational studies. // Ann Pharmacother. — 2008. — Vol.42(7). -Р. 1017-1025.
11. Eddy D. M., Adler J., Patterson B. et al. Individualized guidelines: the potential for
increasing quality and reducing costs. //Ann Intern Med. — 2011. — Vol 154(9). — Р. 627-634.
12. van Oostrom S. H., Picavet H. S., de Bruin S. R. et al. Multimorbidity of chronic diseases
and health care utilization in general practice. // BMC Fam Pract. -2014. — Vol.15. — Р. 61.